Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus - PubMed (original) (raw)

Clinical Trial

Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus

A Vaag et al. J Clin Invest. 1995 Feb.

Abstract

12 identical twin pairs discordant for non-insulin-dependent diabetes mellitus (NIDDM) were studied for insulin sensitivity (euglycemic insulin clamp, 40 mU/m2 per min), hepatic glucose production (HGP, [3-3H]glucose infusion), and insulin secretion (oral glucose tolerance test and hyperglycemic [12 mM] clamp, including glucagon administration). Five of the nondiabetic twins had normal and seven had impaired glucose tolerance. 13 matched, healthy subjects without a family history of diabetes were included as control subjects. The NIDDM twins were more obese compared with their non-diabetic co-twins. The nondiabetic twins were insulin resistant and had a delayed insulin and C-peptide response during oral glucose tolerance tests compared with controls. Furthermore, the nondiabetic twins had a decreased first-phase insulin response and a decreased maximal insulin secretion capacity during hyperglycemic clamping and intravenous glucagon administration. Nondiabetic twins and controls had similar rates of HGP. Compared with both nondiabetic twins and controls, the NIDDM twins had an elevated basal rate of HGP, a further decreased insulin sensitivity, and a further impaired insulin secretion pattern as determined by all tests. In conclusion, defects of both in vivo insulin secretion and insulin action are present in non- and possibly prediabetic twins who possess the necessary NIDDM susceptibility genes. However, all defects of both insulin secretion and glucose metabolism are expressed quantitatively more severely in their identical co-twins with overt NIDDM.

PubMed Disclaimer

Cited by

Identification of Potential Plant-Derived Pancreatic Beta-Cell-Directed Agents Using New Custom-Designed Screening Method: Gymnema sylvestre as an Example.
Al-Romaiyan A, Persaud SJ, Jones PM. Al-Romaiyan A, et al. Molecules. 2023 Dec 28;29(1):194. doi: 10.3390/molecules29010194. Molecules. 2023. PMID: 38202777 Free PMC article. Review.
Partners in diabetes epidemic: A global perspective.
Wang H, Akbari-Alavijeh S, Parhar RS, Gaugler R, Hashmi S. Wang H, et al. World J Diabetes. 2023 Oct 15;14(10):1463-1477. doi: 10.4239/wjd.v14.i10.1463. World J Diabetes. 2023. PMID: 37970124 Free PMC article. Review.
Insulin Resistance and Hypertension: Mechanisms Involved and Modifying Factors for Effective Glucose Control.
Sakr HF, Sirasanagandla SR, Das S, Bima AI, Elsamanoudy AZ. Sakr HF, et al. Biomedicines. 2023 Aug 15;11(8):2271. doi: 10.3390/biomedicines11082271. Biomedicines. 2023. PMID: 37626767 Free PMC article. Review.
iPSCs derived from insulin resistant offspring of type 2 diabetic patients show increased oxidative stress and lactate secretion.
Memon B, Elsayed AK, Bettahi I, Suleiman N, Younis I, Wehedy E, Abou-Samra AB, Abdelalim EM. Memon B, et al. Stem Cell Res Ther. 2022 Aug 20;13(1):428. doi: 10.1186/s13287-022-03123-4. Stem Cell Res Ther. 2022. PMID: 35987697 Free PMC article.
Fasting triglycerides are positively associated with cardiovascular mortality risk in people with diabetes.
Wang Y, Fang Y, Magliano DJ, Charchar FJ, Sobey CG, Drummond GR, Golledge J. Wang Y, et al. Cardiovasc Res. 2023 May 2;119(3):826-834. doi: 10.1093/cvr/cvac124. Cardiovasc Res. 2023. PMID: 35905014 Free PMC article.

References

1. Diabetes. 1967 Aug;16(8):560-5 - PubMed
1. Ann N Y Acad Sci. 1959 Sep 25;82:420-30 - PubMed
1. Metabolism. 1971 Apr;20(4):360-72 - PubMed
1. J Appl Physiol. 1976 Oct;41(4):565-73 - PubMed
1. J Clin Endocrinol Metab. 1979 Jun;48(6):946-54 - PubMed

Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus - PubMed (original) (raw)